INNO-GENE SA ZY -10 (WQ3) — Capital Reinvestment Ratio
Latest as of June 2025:
12.04x
INNO-GENE SA ZY -10 (WQ3) has a Capital Reinvestment Ratio of 12.04x as of June 2025, meaning it reinvests 12% of its operating cash flow (€54.00K) in capital expenditures (€650.00K). See INNO-GENE SA ZY -10 (WQ3) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
12.04x
Capex / Operating Cash Flow
Operating Cash Flow
€54.00K
EUR
Capital Expenditures
€650.00K
EUR
Data as of
Jun 2025
Most recent filing
INNO-GENE SA ZY -10 Capital Reinvestment Ratio (2021–2021)
This chart tracks INNO-GENE SA ZY -10's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for INNO-GENE SA ZY -10 (2021–2021)
Year-by-year Capital Reinvestment Ratio for INNO-GENE SA ZY -10 from 2021 to 2021. For live market cap and broader valuation context, see INNO-GENE SA ZY -10 (WQ3) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.01x | €6.75 Million | €82.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow